| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthesiology | 10 | 2020 | 63 | 2.690 |
Why?
|
| Echocardiography, Transesophageal | 8 | 2014 | 100 | 1.900 |
Why?
|
| Operating Rooms | 8 | 2021 | 108 | 1.890 |
Why?
|
| Facility Design and Construction | 3 | 2021 | 16 | 1.430 |
Why?
|
| Perioperative Care | 4 | 2016 | 100 | 1.310 |
Why?
|
| Conscious Sedation | 4 | 2013 | 61 | 0.950 |
Why?
|
| Pain, Postoperative | 7 | 2017 | 214 | 0.930 |
Why?
|
| Thoracic Surgery | 3 | 2014 | 72 | 0.930 |
Why?
|
| Societies, Medical | 8 | 2014 | 403 | 0.900 |
Why?
|
| Prefrontal Cortex | 14 | 2017 | 640 | 0.860 |
Why?
|
| Ultrasonography, Interventional | 5 | 2016 | 119 | 0.840 |
Why?
|
| Practice Guidelines as Topic | 4 | 2013 | 772 | 0.830 |
Why?
|
| Transcranial Magnetic Stimulation | 13 | 2014 | 413 | 0.820 |
Why?
|
| Patient Safety | 3 | 2021 | 202 | 0.820 |
Why?
|
| Anesthesiologists | 2 | 2022 | 30 | 0.800 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2021 | 33 | 0.770 |
Why?
|
| Echocardiography | 6 | 2014 | 515 | 0.760 |
Why?
|
| Anesthesia | 5 | 2019 | 120 | 0.720 |
Why?
|
| Surgeons | 1 | 2021 | 68 | 0.720 |
Why?
|
| User-Computer Interface | 2 | 2019 | 230 | 0.710 |
Why?
|
| Cardiac Surgical Procedures | 7 | 2014 | 450 | 0.670 |
Why?
|
| Workflow | 4 | 2021 | 100 | 0.660 |
Why?
|
| Gestures | 1 | 2018 | 7 | 0.630 |
Why?
|
| Man-Machine Systems | 1 | 2018 | 7 | 0.630 |
Why?
|
| Humans | 84 | 2022 | 68618 | 0.630 |
Why?
|
| Employee Performance Appraisal | 1 | 2017 | 12 | 0.600 |
Why?
|
| Cardiopulmonary Bypass | 11 | 2013 | 250 | 0.600 |
Why?
|
| Observation | 1 | 2017 | 30 | 0.600 |
Why?
|
| Aprotinin | 7 | 2011 | 55 | 0.590 |
Why?
|
| Postoperative Complications | 5 | 2014 | 1615 | 0.590 |
Why?
|
| Computer Simulation | 5 | 2022 | 706 | 0.580 |
Why?
|
| Intraoperative Care | 4 | 2014 | 91 | 0.580 |
Why?
|
| Pericardium | 2 | 2007 | 97 | 0.550 |
Why?
|
| Cross Infection | 1 | 2018 | 195 | 0.540 |
Why?
|
| Transcranial Direct Current Stimulation | 4 | 2018 | 111 | 0.490 |
Why?
|
| Arthroplasty, Replacement, Knee | 2 | 2013 | 146 | 0.470 |
Why?
|
| Anesthetics, Local | 3 | 2013 | 83 | 0.470 |
Why?
|
| Free Tissue Flaps | 1 | 2014 | 67 | 0.470 |
Why?
|
| Cardiac Output | 2 | 2012 | 133 | 0.460 |
Why?
|
| Nerve Block | 2 | 2013 | 55 | 0.450 |
Why?
|
| Environment Design | 1 | 2013 | 40 | 0.440 |
Why?
|
| Cardiology | 2 | 2013 | 140 | 0.440 |
Why?
|
| Delivery of Health Care | 1 | 2017 | 445 | 0.430 |
Why?
|
| Cardiovascular Surgical Procedures | 2 | 2016 | 36 | 0.430 |
Why?
|
| Hypnotics and Sedatives | 3 | 2004 | 96 | 0.420 |
Why?
|
| Aorta | 3 | 2008 | 316 | 0.420 |
Why?
|
| Pain Perception | 4 | 2014 | 22 | 0.420 |
Why?
|
| Anesthesia, Intravenous | 2 | 2010 | 12 | 0.410 |
Why?
|
| Propofol | 2 | 2004 | 36 | 0.400 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2012 | 174 | 0.400 |
Why?
|
| Analgesics, Opioid | 7 | 2017 | 498 | 0.400 |
Why?
|
| Pain Management | 5 | 2018 | 186 | 0.390 |
Why?
|
| Pain Threshold | 6 | 2018 | 55 | 0.390 |
Why?
|
| Antifibrinolytic Agents | 5 | 2011 | 52 | 0.390 |
Why?
|
| Education, Medical | 1 | 2013 | 147 | 0.380 |
Why?
|
| Intubation, Intratracheal | 2 | 2022 | 99 | 0.380 |
Why?
|
| Intracranial Aneurysm | 1 | 2012 | 87 | 0.380 |
Why?
|
| Databases, Factual | 1 | 2014 | 622 | 0.380 |
Why?
|
| Bioprosthesis | 1 | 2011 | 101 | 0.370 |
Why?
|
| Clinical Competence | 4 | 2022 | 657 | 0.370 |
Why?
|
| Pain | 7 | 2014 | 472 | 0.370 |
Why?
|
| Certification | 1 | 2011 | 66 | 0.360 |
Why?
|
| Internship and Residency | 1 | 2016 | 596 | 0.360 |
Why?
|
| Motor Cortex | 4 | 2017 | 158 | 0.350 |
Why?
|
| Heart Valve Prosthesis | 1 | 2011 | 222 | 0.350 |
Why?
|
| Radiography, Interventional | 2 | 2010 | 49 | 0.350 |
Why?
|
| Male | 49 | 2019 | 37321 | 0.350 |
Why?
|
| Aortic Valve | 1 | 2011 | 249 | 0.350 |
Why?
|
| Trachea | 1 | 2010 | 48 | 0.350 |
Why?
|
| Wounds, Penetrating | 1 | 2010 | 45 | 0.350 |
Why?
|
| Task Performance and Analysis | 2 | 2021 | 150 | 0.350 |
Why?
|
| Analgesia, Patient-Controlled | 4 | 2016 | 29 | 0.340 |
Why?
|
| Bronchoscopy | 2 | 2010 | 147 | 0.340 |
Why?
|
| Serine Proteinase Inhibitors | 4 | 2011 | 48 | 0.340 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2010 | 52 | 0.340 |
Why?
|
| Midazolam | 3 | 1999 | 46 | 0.340 |
Why?
|
| Heart Aneurysm | 2 | 2007 | 21 | 0.330 |
Why?
|
| Head and Neck Neoplasms | 1 | 2014 | 561 | 0.330 |
Why?
|
| Pain Measurement | 11 | 2017 | 328 | 0.330 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2010 | 131 | 0.320 |
Why?
|
| Heart Injuries | 1 | 2008 | 25 | 0.320 |
Why?
|
| Middle Aged | 31 | 2018 | 21147 | 0.320 |
Why?
|
| Analgesia | 5 | 2014 | 58 | 0.310 |
Why?
|
| Cytokines | 6 | 2013 | 866 | 0.310 |
Why?
|
| Functional Laterality | 5 | 2014 | 240 | 0.310 |
Why?
|
| Tranexamic Acid | 4 | 2011 | 37 | 0.310 |
Why?
|
| Coronary Artery Bypass | 4 | 2007 | 218 | 0.300 |
Why?
|
| Radiography, Thoracic | 1 | 2008 | 99 | 0.300 |
Why?
|
| Heart Rupture, Post-Infarction | 1 | 2007 | 7 | 0.300 |
Why?
|
| Accidents, Traffic | 1 | 2008 | 109 | 0.300 |
Why?
|
| Female | 41 | 2019 | 38074 | 0.290 |
Why?
|
| Heart Defects, Congenital | 6 | 2013 | 596 | 0.290 |
Why?
|
| Aneurysm, False | 1 | 2007 | 60 | 0.280 |
Why?
|
| Physical Examination | 1 | 2007 | 152 | 0.280 |
Why?
|
| Embolism, Air | 3 | 2013 | 16 | 0.270 |
Why?
|
| Fibrinolysin | 3 | 2011 | 33 | 0.270 |
Why?
|
| Heart Atria | 2 | 2005 | 206 | 0.270 |
Why?
|
| Treatment Outcome | 13 | 2017 | 7029 | 0.260 |
Why?
|
| Critical Care | 3 | 2018 | 263 | 0.260 |
Why?
|
| Heart Septum | 1 | 2005 | 84 | 0.250 |
Why?
|
| Adult | 27 | 2019 | 21403 | 0.240 |
Why?
|
| Catheterization, Central Venous | 2 | 1995 | 89 | 0.240 |
Why?
|
| Matrix Metalloproteinases | 3 | 2010 | 223 | 0.240 |
Why?
|
| Consciousness | 1 | 2004 | 17 | 0.240 |
Why?
|
| Child | 6 | 2021 | 6405 | 0.240 |
Why?
|
| Infusions, Intravenous | 6 | 2013 | 334 | 0.230 |
Why?
|
| Coronary Circulation | 2 | 2000 | 136 | 0.220 |
Why?
|
| United States | 10 | 2014 | 7367 | 0.220 |
Why?
|
| Analgesia, Epidural | 2 | 2000 | 40 | 0.220 |
Why?
|
| Catheterization | 3 | 2011 | 209 | 0.220 |
Why?
|
| Monitoring, Physiologic | 2 | 2019 | 219 | 0.210 |
Why?
|
| Equipment Failure | 2 | 2013 | 112 | 0.210 |
Why?
|
| Hydromorphone | 2 | 2013 | 14 | 0.210 |
Why?
|
| Methylprednisolone | 2 | 2013 | 99 | 0.200 |
Why?
|
| Aged | 17 | 2017 | 14862 | 0.200 |
Why?
|
| Prospective Studies | 10 | 2013 | 3705 | 0.200 |
Why?
|
| Double-Blind Method | 11 | 2018 | 1738 | 0.200 |
Why?
|
| Hyperalgesia | 2 | 2011 | 18 | 0.190 |
Why?
|
| Simulation Training | 1 | 2022 | 49 | 0.190 |
Why?
|
| Inflammation Mediators | 2 | 2013 | 244 | 0.190 |
Why?
|
| Pilot Projects | 10 | 2018 | 1342 | 0.190 |
Why?
|
| Electric Stimulation Therapy | 2 | 2013 | 147 | 0.180 |
Why?
|
| Single-Blind Method | 4 | 2017 | 249 | 0.180 |
Why?
|
| Glucocorticoids | 2 | 2013 | 222 | 0.180 |
Why?
|
| Medical Errors | 2 | 2018 | 80 | 0.180 |
Why?
|
| Data Display | 1 | 2019 | 17 | 0.170 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 77 | 0.170 |
Why?
|
| Touch Perception | 1 | 2019 | 18 | 0.170 |
Why?
|
| Lorazepam | 1 | 1999 | 54 | 0.170 |
Why?
|
| Exercise Test | 1 | 2000 | 242 | 0.170 |
Why?
|
| Preoperative Care | 3 | 2013 | 275 | 0.170 |
Why?
|
| South Carolina | 5 | 2018 | 2752 | 0.160 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2008 | 2324 | 0.160 |
Why?
|
| Personnel, Hospital | 2 | 2020 | 19 | 0.160 |
Why?
|
| Executive Function | 1 | 2019 | 106 | 0.160 |
Why?
|
| Jugular Veins | 2 | 1995 | 37 | 0.160 |
Why?
|
| Hemostatics | 2 | 2009 | 47 | 0.150 |
Why?
|
| Endothelin A Receptor Antagonists | 2 | 2008 | 22 | 0.150 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2009 | 84 | 0.150 |
Why?
|
| Colony Count, Microbial | 1 | 2018 | 77 | 0.150 |
Why?
|
| Neuromuscular Nondepolarizing Agents | 1 | 1997 | 11 | 0.150 |
Why?
|
| Ventricular Function, Left | 3 | 2013 | 481 | 0.150 |
Why?
|
| Swine | 4 | 2011 | 672 | 0.150 |
Why?
|
| Safety Management | 1 | 2018 | 73 | 0.150 |
Why?
|
| Compartment Syndromes | 1 | 1997 | 13 | 0.140 |
Why?
|
| Myocardial Contraction | 2 | 2009 | 383 | 0.140 |
Why?
|
| Infection Control | 1 | 2018 | 101 | 0.140 |
Why?
|
| Clinical Coding | 1 | 2016 | 21 | 0.140 |
Why?
|
| Blood Loss, Surgical | 3 | 2011 | 79 | 0.140 |
Why?
|
| Trauma Centers | 1 | 2018 | 197 | 0.140 |
Why?
|
| Education, Medical, Graduate | 2 | 2016 | 214 | 0.140 |
Why?
|
| Microdialysis | 3 | 2011 | 147 | 0.140 |
Why?
|
| Ergonomics | 1 | 2016 | 40 | 0.140 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 168 | 0.140 |
Why?
|
| Chloral Hydrate | 1 | 1996 | 5 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2011 | 626 | 0.140 |
Why?
|
| Anesthesia, Dental | 1 | 1996 | 5 | 0.140 |
Why?
|
| Dental Care for Children | 1 | 1996 | 9 | 0.130 |
Why?
|
| Wounds and Injuries | 1 | 1999 | 334 | 0.130 |
Why?
|
| Postoperative Hemorrhage | 2 | 2011 | 69 | 0.130 |
Why?
|
| Tracheoesophageal Fistula | 1 | 1995 | 15 | 0.130 |
Why?
|
| Heart Valve Diseases | 2 | 2013 | 123 | 0.130 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 1995 | 9 | 0.130 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 951 | 0.130 |
Why?
|
| Aminocaproic Acid | 2 | 2010 | 12 | 0.130 |
Why?
|
| Intraoperative Complications | 1 | 1996 | 129 | 0.130 |
Why?
|
| Lumbar Vertebrae | 1 | 2016 | 112 | 0.130 |
Why?
|
| Face | 1 | 1995 | 46 | 0.130 |
Why?
|
| Quality Assurance, Health Care | 2 | 2013 | 177 | 0.130 |
Why?
|
| Gastric Bypass | 2 | 2014 | 83 | 0.130 |
Why?
|
| Endothelins | 3 | 2008 | 57 | 0.120 |
Why?
|
| Treatment Failure | 1 | 2014 | 216 | 0.120 |
Why?
|
| Follow-Up Studies | 3 | 2014 | 3259 | 0.120 |
Why?
|
| Architecture | 1 | 2013 | 2 | 0.120 |
Why?
|
| Surgical Equipment | 1 | 2013 | 6 | 0.120 |
Why?
|
| Engineering | 1 | 2013 | 7 | 0.120 |
Why?
|
| Documentation | 1 | 2014 | 83 | 0.110 |
Why?
|
| Femoral Nerve | 1 | 2013 | 8 | 0.110 |
Why?
|
| Cardiac Catheterization | 1 | 1996 | 419 | 0.110 |
Why?
|
| Fibrinolysis | 2 | 2010 | 55 | 0.110 |
Why?
|
| Perioperative Period | 1 | 2013 | 24 | 0.110 |
Why?
|
| Pericardial Effusion | 1 | 2013 | 15 | 0.110 |
Why?
|
| Automation | 1 | 2013 | 45 | 0.110 |
Why?
|
| Airway Management | 1 | 2013 | 20 | 0.110 |
Why?
|
| Nurses | 1 | 2013 | 53 | 0.110 |
Why?
|
| Fellowships and Scholarships | 1 | 2014 | 127 | 0.110 |
Why?
|
| Injections, Intravenous | 1 | 2013 | 215 | 0.110 |
Why?
|
| Thoracic Injuries | 1 | 2013 | 44 | 0.110 |
Why?
|
| Terminology as Topic | 1 | 2013 | 141 | 0.110 |
Why?
|
| Amides | 1 | 2013 | 86 | 0.110 |
Why?
|
| Retrospective Studies | 6 | 2016 | 7277 | 0.100 |
Why?
|
| Brain Mapping | 3 | 2011 | 532 | 0.100 |
Why?
|
| Odds Ratio | 1 | 2014 | 880 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 1 | 2014 | 329 | 0.100 |
Why?
|
| Curriculum | 1 | 2016 | 575 | 0.100 |
Why?
|
| Spinal Puncture | 2 | 2004 | 38 | 0.100 |
Why?
|
| Thermosensing | 1 | 2011 | 10 | 0.100 |
Why?
|
| Fibromyalgia | 1 | 2011 | 29 | 0.100 |
Why?
|
| Drug Delivery Systems | 1 | 2013 | 236 | 0.100 |
Why?
|
| Specialty Boards | 1 | 2011 | 24 | 0.100 |
Why?
|
| Somatosensory Cortex | 1 | 2011 | 22 | 0.100 |
Why?
|
| Hot Temperature | 4 | 2014 | 152 | 0.090 |
Why?
|
| Chi-Square Distribution | 4 | 2011 | 546 | 0.090 |
Why?
|
| Communication | 1 | 2013 | 329 | 0.090 |
Why?
|
| Isoxazoles | 2 | 2008 | 22 | 0.090 |
Why?
|
| Blood Pressure | 4 | 2007 | 1451 | 0.090 |
Why?
|
| Incidence | 1 | 2014 | 1603 | 0.090 |
Why?
|
| Thiophenes | 2 | 2008 | 76 | 0.090 |
Why?
|
| Heart Septal Defects | 1 | 2010 | 27 | 0.090 |
Why?
|
| Abdominal Pain | 1 | 2011 | 97 | 0.090 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2010 | 85 | 0.090 |
Why?
|
| Dexmedetomidine | 1 | 2010 | 13 | 0.090 |
Why?
|
| Fiber Optic Technology | 1 | 2010 | 40 | 0.090 |
Why?
|
| Anesthetics, Intravenous | 1 | 2010 | 27 | 0.090 |
Why?
|
| Education, Medical, Continuing | 1 | 2011 | 136 | 0.090 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2010 | 106 | 0.090 |
Why?
|
| Physicians | 1 | 2013 | 324 | 0.090 |
Why?
|
| Disease Management | 1 | 2011 | 248 | 0.090 |
Why?
|
| Chronic Pain | 1 | 2011 | 110 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2011 | 453 | 0.080 |
Why?
|
| Prescriptions | 1 | 2009 | 28 | 0.080 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2009 | 37 | 0.080 |
Why?
|
| Decision Making | 1 | 2012 | 410 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 234 | 0.080 |
Why?
|
| Deep Brain Stimulation | 1 | 2010 | 71 | 0.080 |
Why?
|
| Homeostasis | 1 | 2010 | 291 | 0.080 |
Why?
|
| Ketamine | 1 | 2010 | 57 | 0.080 |
Why?
|
| Emotions | 1 | 2010 | 244 | 0.080 |
Why?
|
| Models, Anatomic | 1 | 2009 | 51 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 27 | 0.080 |
Why?
|
| Infant | 4 | 2010 | 2891 | 0.080 |
Why?
|
| Head | 1 | 2009 | 59 | 0.080 |
Why?
|
| Child, Preschool | 4 | 2010 | 3187 | 0.080 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 2077 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2011 | 1745 | 0.080 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2011 | 348 | 0.080 |
Why?
|
| Adolescent | 7 | 2013 | 8912 | 0.070 |
Why?
|
| Placebos | 1 | 2008 | 195 | 0.070 |
Why?
|
| Risk Factors | 2 | 2014 | 5731 | 0.070 |
Why?
|
| Young Adult | 6 | 2014 | 5717 | 0.070 |
Why?
|
| Aneurysm, Ruptured | 1 | 2007 | 40 | 0.070 |
Why?
|
| Aortic Diseases | 1 | 2008 | 113 | 0.070 |
Why?
|
| Infant, Newborn | 4 | 2013 | 2455 | 0.070 |
Why?
|
| Inflammation | 1 | 2013 | 1030 | 0.070 |
Why?
|
| Bupivacaine | 2 | 1997 | 27 | 0.070 |
Why?
|
| Length of Stay | 3 | 2013 | 780 | 0.070 |
Why?
|
| Erythrocyte Transfusion | 2 | 2011 | 72 | 0.070 |
Why?
|
| Models, Neurological | 1 | 2008 | 136 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2013 | 2223 | 0.070 |
Why?
|
| Cardiovascular Agents | 1 | 2007 | 82 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 940 | 0.070 |
Why?
|
| Animals | 7 | 2011 | 20881 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2008 | 277 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2008 | 204 | 0.070 |
Why?
|
| Behavior, Addictive | 1 | 2009 | 317 | 0.070 |
Why?
|
| Reperfusion Injury | 1 | 2008 | 320 | 0.060 |
Why?
|
| Depressive Disorder, Major | 1 | 2010 | 439 | 0.060 |
Why?
|
| Respiration, Artificial | 2 | 2011 | 190 | 0.060 |
Why?
|
| Opioid-Related Disorders | 1 | 2009 | 298 | 0.060 |
Why?
|
| Kidney | 4 | 2011 | 945 | 0.060 |
Why?
|
| Bone Marrow Examination | 1 | 2004 | 6 | 0.060 |
Why?
|
| Injections, Spinal | 1 | 2004 | 18 | 0.060 |
Why?
|
| Heart Diseases | 1 | 2007 | 276 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2008 | 718 | 0.060 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2009 | 239 | 0.060 |
Why?
|
| Myocardium | 4 | 2011 | 1204 | 0.060 |
Why?
|
| Time Factors | 5 | 2013 | 4655 | 0.050 |
Why?
|
| Heart Ventricles | 1 | 2007 | 738 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2010 | 306 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 1140 | 0.050 |
Why?
|
| Biomarkers | 3 | 2013 | 1593 | 0.050 |
Why?
|
| Heart | 3 | 2013 | 850 | 0.050 |
Why?
|
| Thallium Radioisotopes | 1 | 2000 | 13 | 0.050 |
Why?
|
| Dipyridamole | 1 | 2000 | 26 | 0.050 |
Why?
|
| Heart Rate | 2 | 2000 | 568 | 0.050 |
Why?
|
| Dobutamine | 1 | 2000 | 25 | 0.050 |
Why?
|
| Hospitals, University | 1 | 2001 | 169 | 0.050 |
Why?
|
| Intensive Care Units | 2 | 2000 | 344 | 0.050 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2000 | 92 | 0.050 |
Why?
|
| Radiopharmaceuticals | 1 | 2000 | 114 | 0.050 |
Why?
|
| Quadriceps Muscle | 2 | 2010 | 23 | 0.040 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2010 | 112 | 0.040 |
Why?
|
| Medical Staff, Hospital | 1 | 2019 | 44 | 0.040 |
Why?
|
| Cross-Over Studies | 2 | 2011 | 260 | 0.040 |
Why?
|
| Area Under Curve | 2 | 2010 | 238 | 0.040 |
Why?
|
| Workload | 1 | 2020 | 103 | 0.040 |
Why?
|
| Drug Administration Schedule | 2 | 2013 | 567 | 0.040 |
Why?
|
| Magnesium | 1 | 2000 | 110 | 0.040 |
Why?
|
| Nursing Staff, Hospital | 1 | 2019 | 62 | 0.040 |
Why?
|
| Safety | 1 | 1999 | 145 | 0.040 |
Why?
|
| Drug Costs | 1 | 1999 | 87 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 1999 | 193 | 0.040 |
Why?
|
| Electroencephalography | 2 | 2013 | 418 | 0.040 |
Why?
|
| Elasticity | 2 | 2009 | 103 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2011 | 1040 | 0.040 |
Why?
|
| Air Microbiology | 1 | 2018 | 8 | 0.040 |
Why?
|
| Models, Animal | 2 | 2010 | 252 | 0.040 |
Why?
|
| Interleukin-6 | 2 | 2011 | 330 | 0.040 |
Why?
|
| Postoperative Period | 2 | 2010 | 238 | 0.040 |
Why?
|
| Random Allocation | 2 | 2010 | 442 | 0.040 |
Why?
|
| Headache | 1 | 1998 | 68 | 0.040 |
Why?
|
| Critical Illness | 1 | 1999 | 191 | 0.040 |
Why?
|
| Risk Management | 1 | 2018 | 37 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2018 | 78 | 0.040 |
Why?
|
| Pancuronium | 1 | 1997 | 2 | 0.040 |
Why?
|
| Atracurium | 1 | 1997 | 3 | 0.040 |
Why?
|
| Vecuronium Bromide | 1 | 1997 | 4 | 0.040 |
Why?
|
| Androstanols | 1 | 1997 | 7 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 1753 | 0.040 |
Why?
|
| Isoquinolines | 1 | 1997 | 37 | 0.040 |
Why?
|
| Factor Analysis, Statistical | 1 | 2018 | 201 | 0.040 |
Why?
|
| Angina Pectoris | 1 | 1997 | 61 | 0.040 |
Why?
|
| Morphine | 2 | 2008 | 76 | 0.040 |
Why?
|
| Renal Agents | 1 | 1996 | 8 | 0.040 |
Why?
|
| Factor VIII | 1 | 1996 | 27 | 0.040 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 1996 | 15 | 0.040 |
Why?
|
| Plasma Substitutes | 1 | 1996 | 15 | 0.040 |
Why?
|
| Hydroxyethyl Starch Derivatives | 1 | 1996 | 24 | 0.040 |
Why?
|
| Craniotomy | 1 | 1996 | 33 | 0.040 |
Why?
|
| Abdomen | 1 | 1997 | 80 | 0.040 |
Why?
|
| Drug Interactions | 1 | 1997 | 289 | 0.030 |
Why?
|
| Scalp | 1 | 1996 | 47 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2010 | 782 | 0.030 |
Why?
|
| Inhalation | 1 | 1996 | 11 | 0.030 |
Why?
|
| Hydroxyzine | 1 | 1996 | 6 | 0.030 |
Why?
|
| Anesthesia, General | 1 | 1996 | 86 | 0.030 |
Why?
|
| Vena Cava, Superior | 1 | 1996 | 41 | 0.030 |
Why?
|
| Analgesics | 1 | 1997 | 118 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 281 | 0.030 |
Why?
|
| Child Behavior | 1 | 1996 | 56 | 0.030 |
Why?
|
| Cardiac Output, Low | 2 | 2011 | 52 | 0.030 |
Why?
|
| Subclavian Vein | 1 | 1995 | 17 | 0.030 |
Why?
|
| Rupture | 1 | 1995 | 29 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 1995 | 65 | 0.030 |
Why?
|
| Arm | 1 | 1995 | 59 | 0.030 |
Why?
|
| Veins | 1 | 1995 | 68 | 0.030 |
Why?
|
| Acetaminophen | 1 | 1996 | 111 | 0.030 |
Why?
|
| Drug Combinations | 1 | 1996 | 304 | 0.030 |
Why?
|
| Psychophysics | 1 | 2014 | 30 | 0.030 |
Why?
|
| Liver | 2 | 2010 | 1118 | 0.030 |
Why?
|
| Universities | 1 | 1995 | 191 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 1851 | 0.030 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2013 | 38 | 0.030 |
Why?
|
| Hemorrhage | 1 | 1995 | 328 | 0.030 |
Why?
|
| Pulmonary Artery | 2 | 2007 | 323 | 0.030 |
Why?
|
| Benchmarking | 1 | 2013 | 91 | 0.030 |
Why?
|
| Defibrillators, Implantable | 1 | 1996 | 329 | 0.030 |
Why?
|
| Ventricular Function, Right | 1 | 2013 | 103 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2013 | 113 | 0.030 |
Why?
|
| Consensus | 1 | 2013 | 211 | 0.030 |
Why?
|
| Mice | 3 | 2009 | 8474 | 0.030 |
Why?
|
| Neurosurgical Procedures | 1 | 2013 | 98 | 0.030 |
Why?
|
| Movement | 1 | 2013 | 179 | 0.030 |
Why?
|
| Aged, 80 and over | 3 | 2013 | 4848 | 0.030 |
Why?
|
| Factor VIIa | 1 | 2011 | 25 | 0.020 |
Why?
|
| Platelet Transfusion | 1 | 2011 | 21 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2010 | 2550 | 0.020 |
Why?
|
| Sensory Thresholds | 1 | 2011 | 50 | 0.020 |
Why?
|
| Temperature | 1 | 2013 | 341 | 0.020 |
Why?
|
| Hospital Charges | 1 | 2011 | 60 | 0.020 |
Why?
|
| Cold Temperature | 1 | 2011 | 90 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2011 | 133 | 0.020 |
Why?
|
| Pulmonary Embolism | 1 | 2013 | 253 | 0.020 |
Why?
|
| Medical Records | 1 | 2011 | 121 | 0.020 |
Why?
|
| Electrodes | 1 | 2011 | 147 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2011 | 163 | 0.020 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2010 | 50 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 191 | 0.020 |
Why?
|
| Facial Neuralgia | 1 | 2009 | 4 | 0.020 |
Why?
|
| Probability | 1 | 2010 | 245 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2011 | 742 | 0.020 |
Why?
|
| Pain Clinics | 1 | 2009 | 8 | 0.020 |
Why?
|
| Mandibular Diseases | 1 | 2009 | 28 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2010 | 765 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 438 | 0.020 |
Why?
|
| Peroxidase | 1 | 2008 | 40 | 0.020 |
Why?
|
| Transducers | 1 | 2008 | 21 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 181 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2010 | 333 | 0.020 |
Why?
|
| Affect | 1 | 2009 | 218 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 396 | 0.020 |
Why?
|
| Hemostasis | 1 | 2007 | 32 | 0.020 |
Why?
|
| Sensation | 1 | 2008 | 49 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2010 | 517 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 981 | 0.020 |
Why?
|
| Kinetics | 1 | 2009 | 1047 | 0.020 |
Why?
|
| Disease Progression | 1 | 2010 | 1038 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2006 | 87 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 1864 | 0.020 |
Why?
|
| Lidocaine | 1 | 2006 | 36 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2006 | 111 | 0.020 |
Why?
|
| Equipment Design | 1 | 2008 | 500 | 0.020 |
Why?
|
| Epinephrine | 1 | 2006 | 103 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2007 | 179 | 0.020 |
Why?
|
| Blood Coagulation | 2 | 1997 | 123 | 0.020 |
Why?
|
| Neural Inhibition | 1 | 2007 | 80 | 0.020 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2008 | 237 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2009 | 705 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2008 | 1033 | 0.020 |
Why?
|
| Perception | 1 | 2007 | 189 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 1266 | 0.020 |
Why?
|
| Prognosis | 1 | 2010 | 2093 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2011 | 2007 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2007 | 652 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2008 | 689 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2009 | 1330 | 0.010 |
Why?
|
| Depression | 1 | 2011 | 943 | 0.010 |
Why?
|
| Patient Selection | 1 | 2008 | 592 | 0.010 |
Why?
|
| Hematologic Tests | 1 | 2004 | 24 | 0.010 |
Why?
|
| Electrolytes | 1 | 2004 | 47 | 0.010 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2007 | 504 | 0.010 |
Why?
|
| Lung | 1 | 2007 | 849 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 2791 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2009 | 2800 | 0.010 |
Why?
|
| Tachycardia, Ectopic Junctional | 1 | 2000 | 4 | 0.010 |
Why?
|
| Digitalis | 1 | 2000 | 5 | 0.010 |
Why?
|
| Magnesium Deficiency | 1 | 2000 | 6 | 0.010 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2000 | 34 | 0.010 |
Why?
|
| Plants, Toxic | 1 | 2000 | 33 | 0.010 |
Why?
|
| Plants, Medicinal | 1 | 2000 | 43 | 0.010 |
Why?
|
| Phytotherapy | 1 | 2000 | 53 | 0.010 |
Why?
|
| Potassium | 1 | 2000 | 168 | 0.010 |
Why?
|
| Blood Coagulation Tests | 1 | 1997 | 31 | 0.010 |
Why?
|
| Blood Volume | 1 | 1997 | 47 | 0.010 |
Why?
|
| Nitroglycerin | 1 | 1997 | 20 | 0.010 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 1997 | 20 | 0.010 |
Why?
|
| Nitrates | 1 | 1997 | 61 | 0.010 |
Why?
|
| Periosteum | 1 | 1996 | 2 | 0.010 |
Why?
|
| Trochlear Nerve | 1 | 1996 | 3 | 0.010 |
Why?
|
| Thoracic Vertebrae | 1 | 1997 | 52 | 0.010 |
Why?
|
| Isoflurane | 1 | 1996 | 16 | 0.010 |
Why?
|
| Ear, External | 1 | 1996 | 14 | 0.010 |
Why?
|
| Tidal Volume | 1 | 1996 | 17 | 0.010 |
Why?
|
| Anesthetics, Inhalation | 1 | 1996 | 21 | 0.010 |
Why?
|
| Brain | 1 | 2007 | 2176 | 0.010 |
Why?
|
| Occipital Bone | 1 | 1996 | 11 | 0.010 |
Why?
|
| Bone Nails | 1 | 1996 | 32 | 0.010 |
Why?
|
| Tachycardia | 1 | 1996 | 53 | 0.010 |
Why?
|
| Orbit | 1 | 1996 | 30 | 0.010 |
Why?
|
| Partial Thromboplastin Time | 1 | 1996 | 57 | 0.010 |
Why?
|
| Calcium Channel Blockers | 1 | 1997 | 138 | 0.010 |
Why?
|
| Platelet Count | 1 | 1996 | 100 | 0.010 |
Why?
|
| Fentanyl | 1 | 1996 | 26 | 0.010 |
Why?
|
| Temporal Bone | 1 | 1996 | 53 | 0.010 |
Why?
|
| Intracranial Pressure | 1 | 1996 | 58 | 0.010 |
Why?
|
| Fibrinogen | 1 | 1996 | 87 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 1997 | 178 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 1997 | 138 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1996 | 136 | 0.010 |
Why?
|
| Heparin | 1 | 1997 | 205 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 1997 | 189 | 0.010 |
Why?
|
| Fluid Therapy | 1 | 1996 | 59 | 0.010 |
Why?
|
| Elective Surgical Procedures | 1 | 1996 | 95 | 0.010 |
Why?
|
| Calcium | 1 | 2000 | 929 | 0.010 |
Why?
|
| Coronary Disease | 1 | 1997 | 358 | 0.010 |
Why?
|
| Patient Discharge | 1 | 1997 | 294 | 0.010 |
Why?
|
| Recurrence | 1 | 1997 | 948 | 0.010 |
Why?
|
| Anticoagulants | 1 | 1997 | 356 | 0.010 |
Why?
|
| Survival Rate | 1 | 1997 | 1056 | 0.010 |
Why?
|
| Hypertension | 1 | 1996 | 1535 | 0.000 |
Why?
|
| Neoplasms | 1 | 1998 | 1667 | 0.000 |
Why?
|